Anadys Says Hep C Drug Shows Positive Results in Trial

Anadys Pharmaceuticals Inc said its experimental hepatitis C drug, ANA598, showed positive preliminary results in a mid-stage trial, sending its shares up as much as 9 percent in premarket trade.
ABC News